Efficacy of oral supplementation with branched-chain amino acid granules for patients with non-alcoholic fatty liver disease(NAFLD):pilot study
Not Applicable
- Conditions
- nonalcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000007260
- Lead Sponsor
- Iwate Medical University Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1. Subjects with a history of oral branched-chain amino acid granule use within 6 months 2. Patients with branched-chain amino acid metabolism abnormality 3. Diabetes patients treated with insulin 4. Patients with nonalcoholic steatohepatitis 5. Subjects who are judged for non-approved by investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method insulin resistance(HOMA-IR)
- Secondary Outcome Measures
Name Time Method thioredoxin, oxidative stress